兒童疫苗（VFC）市場規模、佔有率和成長分析：按疫苗類型、疾病類型、分銷管道和地區分類－2026-2033年產業預測

2024 年全球「VFC」市場價值為 51.2 億美元，預計到 2025 年將成長至 53.4 億美元，到 2033 年將成長至 74.1 億美元，在預測期（2026-2033 年）內複合年成長率為 4.2%。

全球「免費疫苗接種」（VFC）市場以向符合條件的年輕人提供免費疫苗為特徵，其驅動力在於早期免疫接種對於預防代價高昂的疾病爆發和降低整體醫療保健成本的重要性。該市場已發展壯大，如今涵蓋了除傳統疫苗以外的多種疫苗，包括肺炎球菌疫苗和新冠疫苗，這體現了醫學和公共衛生領域的進步。關鍵成長要素包括聯合疫苗的廣泛應用，聯合疫苗簡化了免疫接種程序並降低了物流成本，從而使更多人能夠獲得疫苗，即使在服務不足的地區也是如此。此外，人工智慧技術透過最佳化需求預測和改善低溫運輸管理，提高了供應鏈效率，從而在確保及時免疫接種的同時最大限度地減少廢棄物和營運成本，進而提升了免費疫苗接種計畫的有效性。

全球「VFC」市場促進因素

全球兒童疫苗市場正受到各國政府加強對常規兒童免疫規劃投入和加強後勤支援的推動。這些規劃正被納入更廣泛的公共衛生策略。這項擴展顯著提高了疫苗的可及性，尤其是在服務不足的地區，這得益於可靠供應鏈的建立和宣傳活動的開展。隨著疫苗可預防疾病相關知識的普及，公眾信心不斷增強，從而提高了免疫接種率。此外，這些協調一致的努力也促成了新疫苗的引入，為兒童提供全面的保護。因此，持續關注提高疫苗可及性正在創造對疫苗產品的強勁需求，進而推動市場成長。

全球「兒童疫苗（VFC）」市場面臨的限制因素

全球「疫苗接種市場」（VFC）面臨嚴峻挑戰，這主要是由於持續存在的關於疫苗安全性的錯誤訊息和文化誤解，加劇了家長的疑慮。這種猶豫往往導致兒童免疫接種被推遲，甚至在某些情況下，家長會直接拒絕接種。社群媒體透過散播毫無根據的恐懼，進一步加劇了這個問題。由於健康素養有限，家長難以區分真實資訊和謠言，而社群媒體很容易誤導他們。此外，醫療專業人員往往時間緊迫，難以充分解答家長的疑問，可能導致疫苗接種進一步延遲。這些因素共同導致免疫接種計劃參與率下降，對新疫苗的需求減少，最終阻礙了市場成長，使潛在銷售無法實現。

兒童疫苗（VFC）市場的全球趨勢

全球疫苗接種市場正經歷著向一體化免疫數位平台的顯著轉變，這主要得益於互通性健康資訊系統的普及應用。該技術使公立和私立醫療機構能夠即時追蹤疫苗庫存、配送計劃和不利事件報告。與國家免疫登記系統同步的「行動優先」應用程式提高了數據準確性，實現了預測性庫存補貨，並減少了缺貨。因此，偏遠地區人口的疫苗接種服務得到加強，循證政策調整得以實施，免疫接種率也提高。總而言之，這種數位融合最佳化了資源配置，使全球疫苗接種市場更有效率且更永續。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球兒童疫苗（VFC）市場規模：以疫苗類型分類

• 聯合疫苗
• 腦膜炎奈瑟菌
• 肺炎球菌
• 輪狀病毒
• 流感
• 水痘
• MMR
• DTaP
• 其他

全球兒童疫苗（VFC）市場規模：依疾病類型分類

• 病毒性的
• 細菌

全球兒童疫苗市場規模：按分銷管道分類

• 公立診所
• 私人供應商
• 社區中心
• 醫院門診病人

全球兒童疫苗市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• GlaxoSmithKline plc
• Merck & Co Inc
• Pfizer Inc
• Sanofi SA
• AstraZeneca plc
• Seqirus
• CSL Limited
• Valneva SE
• Takeda Pharmaceutical Company Limited
• Novavax Inc
• Dynavax Technologies Corporation
• Emergent BioSolutions Inc
• Bavarian Nordic AS
• SinoVac Biotech Ltd
• Bharat Biotech International Ltd
• Serum Institute of India Pvt Ltd
• McKesson Corporation
• Cardinal Health Inc
• AmerisourceBergen Corporation
• Cencora Inc

結論與建議

Global Vaccines For Children (Vfc) Market size was valued at USD 5.12 Billion in 2024 and is poised to grow from USD 5.34 Billion in 2025 to USD 7.41 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The Global Vaccines for Children (VFC) market is characterized by initiatives offering free vaccines to eligible young populations, driven by the need for early immunization to prevent expensive disease outbreaks and lower overall healthcare costs. This market has evolved significantly, now encompassing a wide range of vaccines beyond traditional options, including pneumococcal and COVID-19 vaccines, showcasing advancements in medical science and commitment to public health. Key growth factors include the increasing use of combination vaccines that simplify vaccination schedules and reduce logistical costs, facilitating broader access in underserved areas. Furthermore, AI technologies are enhancing supply chain efficiencies through optimized demand forecasting and improved cold-chain management, enabling timely immunizations while minimizing waste and operational costs, thus promoting a more effective VFC program.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vaccines For Children (Vfc) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vaccines For Children (Vfc) Market Segments Analysis

Global vaccines for children (vfc) market is segmented by vaccine type, disease type, distribution channel and region. Based on vaccine type, the market is segmented into Combos, Meningococcal, Pneumococcal, Rotavirus, Influenza, Varicella, MMR, DTaP and Others. Based on disease type, the market is segmented into Viral and Bacterial. Based on distribution channel, the market is segmented into Public Clinics, Private Providers, Community Centers and Hospital Outpatients. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Vaccines For Children (Vfc) Market

The Global Vaccines For Children (VFC) market is being propelled by heightened government investments and enhanced logistical support aimed at routine childhood vaccination programs, which are now being integrated into wider public health strategies. This expansion significantly enhances vaccine accessibility, especially in underserved areas, by creating reliable supply chains and outreach efforts. As education about vaccine-preventable diseases improves, public trust increases, leading to higher participation rates in vaccination initiatives. Additionally, these coordinated actions enable the introduction of newer vaccines, providing children with comprehensive protection. As a result, the sustained focus on improving vaccination accessibility fosters robust demand for vaccine products, thereby bolstering market growth.

Restraints in the Global Vaccines For Children (Vfc) Market

The Global Vaccines for Children market faces significant challenges due to ongoing misinformation and cultural misunderstandings regarding vaccine safety, which foster skepticism among parents. This hesitancy often results in delayed or outright refusal of recommended childhood immunizations. The role of social media in perpetuating unfounded fears compounds the issue, as it can mislead parents who struggle to distinguish between legitimate information and baseless rumors due to limited health literacy. Additionally, healthcare providers, often pressed for time, may find it challenging to address parental concerns adequately, which can lead to further delays in vaccine administration. These factors collectively contribute to reduced enrollment in immunization programs and decreased demand for new vaccines, ultimately hindering market growth as potential sales remain unrealized.

Market Trends of the Global Vaccines For Children (Vfc) Market

The Global Vaccines for Children (VFC) market is witnessing a significant trend towards integrated immunization digital platforms, driven by the adoption of interoperable health information systems. This technology facilitates real-time tracking of vaccine inventories, delivery schedules, and adverse event reporting across both public and private healthcare providers. Mobile-first applications that synchronize with national immunization registries are improving data accuracy, enabling predictive restocking, and reducing stockouts. As a result, outreach to remote populations is enhanced, supporting evidence-based policy adjustments that drive higher vaccination coverage rates. Overall, this digital convergence is optimizing the allocation of resources, making the VFC market more efficient and sustainable worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Vaccines For Children (VFC) Market Size by Vaccine Type & CAGR (2026-2033)

• Market Overview
• Combos
• Meningococcal
• Pneumococcal
• Rotavirus
• Influenza
• Varicella
• MMR
• DTaP
• Others

Global Vaccines For Children (VFC) Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Viral
• Bacterial

Global Vaccines For Children (VFC) Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Public Clinics
• Private Providers
• Community Centers
• Hospital Outpatients

Global Vaccines For Children (VFC) Market Size & CAGR (2026-2033)

• North America (Vaccine Type, Disease Type, Distribution Channel)
  • US
  • Canada
• Europe (Vaccine Type, Disease Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Disease Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Disease Type, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Disease Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seqirus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valneva SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novavax Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic AS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SinoVac Biotech Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech International Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India Pvt Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cencora Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations